This market resolves to "YES" if a human trial of an artificial uterus* is initiated by October 15.

* "The artificial uterus works in two ways: First, by connecting the fetus' umbilical cord to an oxygenator, which circulates the blood and places it in a fluid sac, mimicking the womb and allowing the fetus to breathe and swallow amniotic fluid as it does during development in the uterus."

Resolution will be based on publicly available reporting as of October 15.

- - - - - - - - - - -

https://www.dailymail.co.uk/sciencetech/article-12927021/Artificial-uterus-human-trials-2024.html

..."The Food and Drug Administration (FDA) has met with experts to discuss the following steps to bring the artificial uterus, called EXTEND, into human trials - and is set to announce a decision later this year."

..."In September, the FDA held a meeting with more than 24 experts, including neonatologists, pediatricians, and bioethicists, to discuss what steps to take to conduct a human trial.

During the meeting, Alan Flake, one of EXTEND's developers, said he believes the team's preclinical data 'is adequate for consideration of a carefully designed clinical study.'

The FDA is expected to announce its decision later this year."